VitaNova Life Sciences Corp

VNOV OTC SEC CIK 1699709
Follow VitaNova Life Sciences Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $321.6K +209.5% vs same quarter last year
Net income −$123.1K −165.9% vs same quarter last year
EPS, diluted −$0.01
Operating cash flow $7K −97.4% vs same quarter last year
Revenue by quarter
$292.1K
$308.3K
$2M
$103.9K
$427.1K
$709.6K
$1.8M
$321.6K
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$1M$0$1M$2M$3M$4MFY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$3M−$37.3K
FY25$2.7M$850.7K
FY24$570.7K$140.9K
FY23$38K−$24.2K
FY22$120K$139.7K
FY21$0−$52.1K
FY20$0−$72.3K
FY19$0−$106.2K
FY18$0−$1.6K
FY17$0−$7.2K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%150%FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2630.1%0.1%−1.2%
FY2559.2%45.4%32%
FY2466.2%36%24.7%
FY23100%−63.8%−63.8%
FY22-−11.1%116.4%
FY21---
FY20---
FY19---
FY18---
FY17---
Net margin vs the sectorMedian of Consumer companies filing with the SEC
  • VitaNova Life Sciences
  • Consumer median
−100%−50%0%50%100%150%FY18FY20FY22FY24FY26
Show the numbers
YearVitaNova Life SciencesConsumer median
FY26−1.2%1.7%
FY2532%1.1%
FY2424.7%1.5%
FY23−63.8%2.1%
FY22116.4%2.5%
FY21-2.5%
FY20-1.8%
FY19-2.6%
FY18-3.8%
FY17-3.8%